One of the first questions patients ask before starting treatment is: how much does tirzepatide cost?
And it’s a fair question. The price range is enormous — from as little as $25/month to over $1,086/month — depending entirely on how you access it. This guide breaks down every pricing scenario in plain terms so you know exactly what to expect in 2026.
The Short Answer: Tirzepatide Price Snapshot for 2026
| Access Method | Monthly Cost |
|---|---|
| Brand-name (no insurance) | $1,059–$1,086/month |
| Brand-name with insurance + savings card | As low as $25/month |
| LillyDirect self-pay vials | $299–$499/month |
| Physician-supervised compounded program | $349–$499/month |
| Medicare (weight loss) | Mostly not covered |
Understanding where you fall in this range takes just a few minutes of research — and the right provider can walk you through your options on a free consultation call.
Brand-Name Tirzepatide: Mounjaro vs. Zepbound
Tirzepatide is sold under two brand names by Eli Lilly:
- Mounjaro® — FDA-approved for type 2 diabetes
- Zepbound® — FDA-approved for chronic weight management and obstructive sleep apnea
Both contain the same active ingredient. The price at retail pharmacies (CVS, Walgreens, Rite Aid) for either brand runs $1,059–$1,086 per 28-day supply without insurance. That’s roughly $12,700–$13,000 per year out of pocket.
Most people cannot — and should not have to — pay that.
With Insurance: What Do You Actually Pay?
This is where things get complicated. Coverage depends on:
- Your plan type — commercial, Medicare, Medicaid, VA, TRICARE.
- The indication — diabetes (Mounjaro) or weight loss (Zepbound).
- Prior authorization status — many plans require it.
Commercial Insurance
Most commercial plans cover Mounjaro for diabetes more readily than Zepbound for obesity. With the Eli Lilly Savings Card, eligible commercially insured patients can pay as little as $25/month for up to 12 fills per year.
Zepbound coverage is harder to obtain. Most insurers classify obesity medications as “lifestyle” and exclude them. Prior authorization is frequently required — and often denied on the first attempt.
Medicare
Medicare generally does not cover Zepbound for weight management. Mounjaro may be covered under Part D when prescribed for diabetes. However, starting in July 2026, CMS is introducing a Medicare GLP-1 Bridge that may create early access for some Medicare patients — though full coverage remains limited.
Medicaid
Medicaid coverage varies by state. Some states cover tirzepatide for certain conditions. Check your state’s Medicaid formulary directly.
LillyDirect Self-Pay Vials: A Middle Path
In 2024, Eli Lilly launched single-dose vials through their direct-to-consumer pharmacy — LillyDirect. These contain the same tirzepatide as the branded pens, but in vial format at significantly lower self-pay prices.
As of 2026:
| Dose | LillyDirect Self-Pay Price |
|---|---|
| 2.5 mg | ~$299/month |
| 5 mg | ~$399/month |
| 7.5–15 mg | ~$499/month |
You still need a valid prescription from a licensed US provider to use LillyDirect. And you must refill within 45 days to keep the discounted pricing. Miss that window, and standard list pricing applies.
Compounded Tirzepatide: Is It Still Available in 2026?
This is the most frequently asked question about tirzepatide pricing in 2026.
The short answer: yes, but the landscape has changed significantly.
During the 2023–2024 drug shortage period, the FDA allowed widespread compounding. That shortage designation was lifted in early 2025. As a result, bulk compounding for general commercial distribution is no longer FDA-permitted.
However, Section 503A patient-specific compounding is still legal when a licensed physician documents a medical necessity for an individualized formulation. This is how physician-supervised telehealth platforms continue to provide compounded tirzepatide to qualifying patients.
If a provider is still offering compounded tirzepatide in 2026, verify that they work with a licensed 503A-registered compounding pharmacy and that prescriptions are written individually by a licensed physician — not via a generalized standing order.
See the FDA’s official guidance on this at FDA.gov Human Drug Compounding.
How Much Does Tirzepatide Cost Through Physician-Supervised Programs?
Programs like Tirzepatide Medics offer compounded tirzepatide through licensed physicians at a fraction of the brand-name cost.
| Plan | Price | Savings vs. Brand-Name |
|---|---|---|
| Monthly | $399/month | ~$687/month saved |
| 3-Month | $1,125 total ($375/month) | ~$700+/month |
| 6-Month | $2,199 total ($366/month) | ~$720+/month |
Every plan includes:
- Licensed physician evaluation
- Physician-supervised treatment
- Medication (compounded tirzepatide)
- Syringes and alcohol swabs
- Free shipping
- Ongoing medical support and follow-up
For a full breakdown, visit the pricing page.
Hidden Costs to Watch For
When comparing tirzepatide programs, the listed price isn’t always the final price. Here’s what to check:
- Separate consultation fees — some platforms charge $50–$100/month for provider access on top of the medication price.
- Membership fees — a few telehealth companies charge monthly membership fees in addition to medication.
- Escalating dose pricing — some providers charge higher monthly rates as your dose increases. Flat-rate pricing is more predictable.
- Shipping fees — always verify whether shipping is included.
Transparent, all-in pricing with no hidden fees is a sign of a reputable provider. The tirzepatide treatment page explains exactly what’s included.
What About Oral Tirzepatide Pricing?
Compounded oral tirzepatide (dissolving sublingual tablet) is an increasingly popular needle-free alternative. Pricing is typically comparable to injectable compounded programs — usually in the $350–$449/month range, depending on the provider.
This format appeals to patients who prefer not to inject. Explore the oral tirzepatide option to see if it’s right for you.
A Real-World Cost Comparison: Jennifer’s Story
Jennifer, a 46-year-old nurse from Texas, was prescribed Zepbound by her primary care doctor. Her insurance denied coverage. The out-of-pocket cost at her local pharmacy was $1,086/month — way outside her budget.
After researching her options, she found a telehealth program with physician supervision. Her monthly cost dropped to $399. Within 6 months, she lost 28 pounds. She describes the savings as “money that actually went toward something that worked.”
Jennifer’s experience mirrors what hundreds of patients report: the brand-name price is not the only option. With the right provider, how much does tirzepatide cost becomes a much more manageable number.
How to Get Started Without Overpaying
Here’s the fastest route to affordable, medically supervised tirzepatide in 2026:
- Schedule a free consultation — no out-of-pocket cost just to find out if you qualify
- Discuss your insurance situation — your provider can help you evaluate whether coverage makes sense
- Choose a transparent pricing plan — flat-rate, all-inclusive plans with free shipping are best
- Start treatment — medication typically ships within 5–10 business days of approval
Book your free consultation here to get started.
FAQ
How much does tirzepatide cost without insurance in 2026?
Brand-name Mounjaro/Zepbound runs $1,059–$1,086/month; physician-supervised compounded programs typically cost $349–$499/month.
Is tirzepatide covered by Medicare?
Medicare generally does not cover Zepbound for weight loss; Mounjaro may be covered under some Part D plans when prescribed for type 2 diabetes.
Can I get tirzepatide for $25/month?
Yes — but only if you have qualifying commercial insurance and use the Eli Lilly Savings Card; Medicare and Medicaid patients are excluded from this program.
Why is compounded tirzepatide cheaper?
Compounding pharmacies prepare patient-specific medications outside the brand-name manufacturing process, bypassing marketing and distribution markups.
Does the price go up as my dose increases?
With flat-rate programs, the monthly price stays the same regardless of dose; tiered pricing programs charge more at higher doses.
Is cheap tirzepatide a red flag?
Prices under $200/month with no physician oversight warrant caution — always verify the provider uses a licensed US compounding pharmacy and a licensed prescriber.

